OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature
Yining Gao, Jie Pan, Dingding Shen, et al.
Brain Sciences (2022) Vol. 12, Iss. 6, pp. 773-773
Open Access | Times Cited: 15
Yining Gao, Jie Pan, Dingding Shen, et al.
Brain Sciences (2022) Vol. 12, Iss. 6, pp. 773-773
Open Access | Times Cited: 15
Showing 15 citing articles:
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes
Antonio Farina, Macarena Villagrán‐García, Alberto Vogrig, et al.
The Lancet Neurology (2023) Vol. 23, Iss. 1, pp. 81-94
Open Access | Times Cited: 40
Antonio Farina, Macarena Villagrán‐García, Alberto Vogrig, et al.
The Lancet Neurology (2023) Vol. 23, Iss. 1, pp. 81-94
Open Access | Times Cited: 40
MRI characteristics of chemotherapy-related central neurotoxicity: a pictorial review
Mina F. G. Isaac, Rugaiyah Alkhatib, Chi Long Ho
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Mina F. G. Isaac, Rugaiyah Alkhatib, Chi Long Ho
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Antibody-positive paraneoplastic neurological syndromes associated with immune checkpoint inhibitors: a systematic review
Le Zhang, Siyuan Fan, Jiawei Wang, et al.
Journal of Neurology (2025) Vol. 272, Iss. 3
Closed Access
Le Zhang, Siyuan Fan, Jiawei Wang, et al.
Journal of Neurology (2025) Vol. 272, Iss. 3
Closed Access
Immune Checkpoint Inhibitor-Induced Autoimmune Encephalitis in Metastatic Squamous Cell Lung Cancer
Junhui Wang, Qinhong Zheng, Jianxin Chen
Immunotherapy (2023) Vol. 15, Iss. 6, pp. 409-416
Open Access | Times Cited: 6
Junhui Wang, Qinhong Zheng, Jianxin Chen
Immunotherapy (2023) Vol. 15, Iss. 6, pp. 409-416
Open Access | Times Cited: 6
Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer
Takaaki Tanaka, Masataka Taoka, Go Makimoto, et al.
Internal Medicine (2023) Vol. 63, Iss. 9, pp. 1261-1267
Open Access | Times Cited: 6
Takaaki Tanaka, Masataka Taoka, Go Makimoto, et al.
Internal Medicine (2023) Vol. 63, Iss. 9, pp. 1261-1267
Open Access | Times Cited: 6
Autoimmune encephalitis following treatment with durvalumab for small-cell lung cancer
Yu-Lan Qian, Ye Jiang, Yinhua Gong, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 10
Open Access | Times Cited: 1
Yu-Lan Qian, Ye Jiang, Yinhua Gong, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 10
Open Access | Times Cited: 1
Autoimmune Encephalitis following Checkpoint Inhibitor Therapy in a Patient with Metastatic Melanoma in Complete Remission
Giuseppe Civardi, Alessia Medioli, Carlotta Braghieri, et al.
Medicina (2024) Vol. 60, Iss. 5, pp. 728-728
Open Access | Times Cited: 1
Giuseppe Civardi, Alessia Medioli, Carlotta Braghieri, et al.
Medicina (2024) Vol. 60, Iss. 5, pp. 728-728
Open Access | Times Cited: 1
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment
Stefania Cuzzubbo, Alain Carpentier
Current Opinion in Neurology (2022) Vol. 35, Iss. 6, pp. 814-822
Closed Access | Times Cited: 6
Stefania Cuzzubbo, Alain Carpentier
Current Opinion in Neurology (2022) Vol. 35, Iss. 6, pp. 814-822
Closed Access | Times Cited: 6
Protective effect of resveratrol against pembrolizumab‐induced hepatotoxicity and neurotoxicity in male rats
Neşe Başak Türkmen, Hande Yüce, Yasemin Şahin, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 37, Iss. 3
Closed Access | Times Cited: 4
Neşe Başak Türkmen, Hande Yüce, Yasemin Şahin, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 37, Iss. 3
Closed Access | Times Cited: 4
Pembrolizumab-induced encephalitis in a patient with renal cell carcinoma post nephrectomy: A case report
Amit Sharma, Akhil Chapagain, Sanjeev Kharel, et al.
SAGE Open Medical Case Reports (2023) Vol. 11
Open Access | Times Cited: 2
Amit Sharma, Akhil Chapagain, Sanjeev Kharel, et al.
SAGE Open Medical Case Reports (2023) Vol. 11
Open Access | Times Cited: 2
Autoimmune Encephalitis Following Check Point Inhibitor Therapy in a Patient with Metastatic Melanoma in Complete Remission
Giuseppe Civardi, Alessia Medioli, Carlotta Braghieri, et al.
(2024)
Open Access
Giuseppe Civardi, Alessia Medioli, Carlotta Braghieri, et al.
(2024)
Open Access
Toxicity profiles of immune checkpoint inhibitors in nervous system cancer: a comprehensive disproportionality analysis using FDA adverse event reporting system
Rongrong Liu, Hui Zhao, Zenghong Lu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
Rongrong Liu, Hui Zhao, Zenghong Lu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
Brain Freeze: Pembrolizumab-Induced Autoimmune Encephalitis in Triple-Negative Breast Cancer
Shanu Modi, Charishma Bhimineni, Malay Rathod, et al.
Cureus (2024)
Open Access
Shanu Modi, Charishma Bhimineni, Malay Rathod, et al.
Cureus (2024)
Open Access
Central nervous system complications of immune checkpoint inhibitors: a comprehensive review
Sébastien Lopes, L. Pabst, Thibault Bahougne, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 206, pp. 104595-104595
Open Access
Sébastien Lopes, L. Pabst, Thibault Bahougne, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 206, pp. 104595-104595
Open Access
